Polyrizon Ltd Ordinary Net Income
| PLRZ Stock | 13.85 0.14 1.00% |
As of the 14th of February 2026, Polyrizon holds the Semi Deviation of 7.16, coefficient of variation of 728.0, and Risk Adjusted Performance of 0.1205. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Polyrizon, as well as the relationship between them.
Polyrizon's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Polyrizon's valuation are provided below:We have found seventy-one available trending fundamental ratios for Polyrizon Ordinary, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to check out all of Polyrizon Ordinary recent market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. | Last Reported | Projected for Next Year | ||
| Net Loss | -1.4 M | -1.3 M | |
| Net Loss | -1.4 M | -1.5 M | |
| Net Loss | (126.41) | (132.73) |
Polyrizon | Net Income | Build AI portfolio with Polyrizon Stock |
The evolution of Net Income for Polyrizon Ltd Ordinary provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Polyrizon compares to historical norms and industry peers.
Latest Polyrizon's Net Income Growth Pattern
Below is the plot of the Net Income of Polyrizon Ltd Ordinary over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Polyrizon Ordinary financial statement analysis. It represents the amount of money remaining after all of Polyrizon Ltd Ordinary operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Polyrizon's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Polyrizon's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (1.54 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Polyrizon Net Income Regression Statistics
| Arithmetic Mean | (420,557) | |
| Coefficient Of Variation | (127.35) | |
| Mean Deviation | 449,780 | |
| Median | (73,000) | |
| Standard Deviation | 535,590 | |
| Sample Variance | 286.9B | |
| Range | 1.5M | |
| R-Value | (0.82) | |
| Mean Square Error | 101.1B | |
| R-Squared | 0.67 | |
| Significance | 0.000059 | |
| Slope | (86,792) | |
| Total Sum of Squares | 4.6T |
Polyrizon Net Income History
Other Fundumenentals of Polyrizon Ordinary
Polyrizon Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Polyrizon is extremely important. It helps to project a fair market value of Polyrizon Stock properly, considering its historical fundamentals such as Net Income. Since Polyrizon's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Polyrizon's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Polyrizon's interrelated accounts and indicators.
Click cells to compare fundamentals
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Polyrizon. Anticipated expansion of Polyrizon directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Polyrizon assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding Polyrizon Ordinary requires distinguishing between market price and book value, where the latter reflects Polyrizon's accounting equity. The concept of intrinsic value - what Polyrizon's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Polyrizon's price substantially above or below its fundamental value.
It's important to distinguish between Polyrizon's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Polyrizon should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Polyrizon's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Polyrizon 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Polyrizon's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Polyrizon.
| 11/16/2025 |
| 02/14/2026 |
If you would invest 0.00 in Polyrizon on November 16, 2025 and sell it all today you would earn a total of 0.00 from holding Polyrizon Ltd Ordinary or generate 0.0% return on investment in Polyrizon over 90 days. Polyrizon is related to or competes with Cyclerion Therapeutics, XTL Biopharmaceutica, Alaunos Therapeutics, Pasithea Therapeutics, Quoin Pharmaceuticals, Vyne Therapeutics, and PharmaCyte Biotech. Polyrizon is entity of United States. It is traded as Stock on NASDAQ exchange. More
Polyrizon Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Polyrizon's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Polyrizon Ltd Ordinary upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 8.21 | |||
| Information Ratio | 0.1343 | |||
| Maximum Drawdown | 149.99 | |||
| Value At Risk | (15.16) | |||
| Potential Upside | 31.36 |
Polyrizon Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Polyrizon's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Polyrizon's standard deviation. In reality, there are many statistical measures that can use Polyrizon historical prices to predict the future Polyrizon's volatility.| Risk Adjusted Performance | 0.1205 | |||
| Jensen Alpha | 2.91 | |||
| Total Risk Alpha | 1.44 | |||
| Sortino Ratio | 0.3764 | |||
| Treynor Ratio | 0.7972 |
Polyrizon February 14, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1205 | |||
| Market Risk Adjusted Performance | 0.8072 | |||
| Mean Deviation | 10.97 | |||
| Semi Deviation | 7.16 | |||
| Downside Deviation | 8.21 | |||
| Coefficient Of Variation | 728.0 | |||
| Standard Deviation | 23.0 | |||
| Variance | 529.18 | |||
| Information Ratio | 0.1343 | |||
| Jensen Alpha | 2.91 | |||
| Total Risk Alpha | 1.44 | |||
| Sortino Ratio | 0.3764 | |||
| Treynor Ratio | 0.7972 | |||
| Maximum Drawdown | 149.99 | |||
| Value At Risk | (15.16) | |||
| Potential Upside | 31.36 | |||
| Downside Variance | 67.39 | |||
| Semi Variance | 51.2 | |||
| Expected Short fall | (15.29) | |||
| Skewness | 4.23 | |||
| Kurtosis | 20.19 |
Polyrizon Ordinary Backtested Returns
Polyrizon is very risky given 3 months investment horizon. Polyrizon Ordinary maintains Sharpe Ratio (i.e., Efficiency) of 0.16, which implies the firm had a 0.16 % return per unit of risk over the last 3 months. We were able to interpolate data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 3.72% are justified by taking the suggested risk. Use Polyrizon Coefficient Of Variation of 728.0, semi deviation of 7.16, and Risk Adjusted Performance of 0.1205 to evaluate company specific risk that cannot be diversified away. Polyrizon holds a performance score of 12 on a scale of zero to a hundred. The company holds a Beta of 3.95, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Polyrizon will likely underperform. Use Polyrizon semi variance, rate of daily change, and the relationship between the value at risk and kurtosis , to analyze future returns on Polyrizon.
Auto-correlation | 0.42 |
Average predictability
Polyrizon Ltd Ordinary has average predictability. Overlapping area represents the amount of predictability between Polyrizon time series from 16th of November 2025 to 31st of December 2025 and 31st of December 2025 to 14th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Polyrizon Ordinary price movement. The serial correlation of 0.42 indicates that just about 42.0% of current Polyrizon price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.42 | |
| Spearman Rank Test | 0.08 | |
| Residual Average | 0.0 | |
| Price Variance | 2.39 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Polyrizon Ltd Ordinary reported net income of (1.54 Million). This is 100.45% lower than that of the Biotechnology sector and 102.21% lower than that of the Health Care industry. The net income for all United States stocks is 100.27% higher than that of the company.
Polyrizon Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Polyrizon's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Polyrizon could also be used in its relative valuation, which is a method of valuing Polyrizon by comparing valuation metrics of similar companies.Polyrizon is currently under evaluation in net income category among its peers.
Polyrizon Fundamentals
| Return On Equity | -0.12 | ||||
| Return On Asset | -0.22 | ||||
| Current Valuation | 14.86 M | ||||
| Shares Outstanding | 1.04 M | ||||
| Shares Owned By Insiders | 19.98 % | ||||
| Shares Owned By Institutions | 0.06 % | ||||
| Number Of Shares Shorted | 51.38 K | ||||
| Price To Book | 0.78 X | ||||
| EBITDA | (1.42 M) | ||||
| Net Income | (1.54 M) | ||||
| Total Debt | 261 K | ||||
| Book Value Per Share | 18.75 X | ||||
| Cash Flow From Operations | (1.15 M) | ||||
| Short Ratio | 0.36 X | ||||
| Earnings Per Share | (1.22) X | ||||
| Market Capitalization | 14.57 M | ||||
| Total Asset | 5.55 M | ||||
| Retained Earnings | (5.07 M) | ||||
| Working Capital | 2.39 M | ||||
| Net Asset | 5.55 M |
About Polyrizon Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Polyrizon Ltd Ordinary's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Polyrizon using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Polyrizon Ltd Ordinary based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Polyrizon Stock Analysis
When running Polyrizon's price analysis, check to measure Polyrizon's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Polyrizon is operating at the current time. Most of Polyrizon's value examination focuses on studying past and present price action to predict the probability of Polyrizon's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Polyrizon's price. Additionally, you may evaluate how the addition of Polyrizon to your portfolios can decrease your overall portfolio volatility.